Monthly Archives: April 2025

Technology is transforming every aspect of human life; healthcare is no exception. The Health Community of West Africa (HCOWA) Association of Ghana took a bold step forward by hosting its 5th seminar on the development and application of Smart Chinese Medicine in healthcare. Held on April 4th, 2025, at the HCOWA headquarters, La Trade Fair, this event brought together leading herbal medical practitioners from China and Ghana.

Under the theme, “Bridging Tradition and Technology: AI-Driven Innovations in Africa and Chinese Medicine,” the seminar explored how artificial intelligence can revolutionize the development, application, and regulation of herbal medicine. The event featured prominent voices in the field, including Dr. Yakubu Tubor Yusuf, Okogye Abibiduro Nana Kwadwo Obiri, Dr. (Med) Ohene Kwabena Safo, Dr. MH. Sandra Ashong, and renowned Chinese AI-TCM experts.

Key Discussions and Insights.

Among the guest speakers was Doctor Yusuf Yakubu, the Registrar for the Traditional Medicine Practice Council (TMPC) Ghana. He’s a proud graduate of Kwame Nkrumah University of Science and Technology (KNUST) who earned his Bachelor of Herbal Medicine in 2014. He further deepened his expertise at the Centre for Plant Medicine Research in Mampong from 2015 to 2017 and through clinical training at Tetteh Quarshie Hospital. His unique knowledge of both traditional and modern practices positions him as a strong advocate for the regulation and standardization of herbal medicine.

In his speech, Dr. Yusuf highlighted the significance of traditional healing practices in Africa and China, emphasizing their comprehensive frameworks of knowledge refined over generations. He noted that artificial intelligence can amplify this ancestral wisdom and acknowledges the crucial role traditional medicine has played in global healthcare, inspiring modern pharmaceuticals and continuing to revolutionize the field.

Adding further insights was the President of the Ghana Association of Medical Herbalists, Dr. MH Sandra Ashong. She is a renowned herbal and medical practitioner with a decade and a half of experience in diverse technical know-how in traditional and alternative medicine, especially medical herbalism. She is currently the head of the Complementary and Alternative Medicine unit at the Lekma Hospital, having studied herbal medicine at the Kwame Nkrumah University of Science and Technology. She also has an MBA in Health Service Management.

“The herbal medicine industry is made up of regulation, research, clinical medicine practice, manufacturing, cultivation and education, which are striving to enhance their progress to meet the demands and expectations of their customers, utilizing various methodologies. The herbal medicine industry is a critical field that plays a vital role in saving lives. It should now operate based on continuous innovation and the adoption of new technologies to address healthcare issues and its challenges.” Dr. Ashong said.

She further explained how artificial intelligence (AI) technologies have now been explored in all fields and disciplines of herbal medicine by herbal medicine experts, including medical herbalists in recent years.

In addition to the above, the General Secretary of the Ghana Federation of Traditional Medicine Practitioners Association (GHAFTRAM), Mr. Okogye Abibiduro Nana Kwadwo Obiri, a distinguished traditional medicine practitioner and director of the Obiri Herbal Research Centre located at New Weija, Ghana, with over three decades of experience since 1989, also gave his speech.

He holds a traditional practitioner’s license from the Traditional Medicine Practice Council (TMPC) of Ghana, granted in 2009. His educational background includes a certificate in Basic Science in Herbal Medicine Production from Kwame Nkrumah University of Science and Technology (KNUST)—WHO Training for Traditional Medicine Practitioners (2012).

During his speech, he concluded by saying that “the future of traditional medicine in Africa is bright, and AI is the key to unlocking its full potential. By leveraging AI, we can modernize traditional medicine, enhance its credibility, and expand its reach to benefit millions. GHAFTRAM stands ready to champion this transformation, ensuring that traditional medicine continues to play a vital role in Africa’s healthcare system hence let us embrace innovation, foster collaboration, and work towards a future where AI and traditional medicine complement each other to create a healthier, more inclusive world.”

Next was Dr Ohene Kwabena Safo, a graduate of the University of Ghana Medical School, where he earned a Bachelor of Medicine and a Bachelor of Surgery degree. He is currently in specialist training with Ghana College for Physicians and Surgeons. He is a Quality Consultant, CEO of the OKS Group, the Vice President of the Private Health Facilities Association of Ghana (Greater Accra) and the General Manager for Kantanka Herbal Pharmaceuticals and Research Centre.

During his speech, He emphasized on the significant impact of technology on his practice, enabling him to effortlessly track patients’ medical records and swiftly identify potential risks. He also explored innovative solutions, such as utilizing drones for doorstep medicine delivery and introducing a cutting-edge ring device that allows him to supervise patients on managing their personal health records.

Additionally, he explained how AI is driving positive change in production and use of herbal medicine Stressing on the 3 Ps that is Practice, Production and Professionalism, he elaborated on the value of standardization and it how it can assist seamless merge of tradition and technology.

Fostering Collaboration and Future Integration.

The seminar concluded with interactive discussions and socialization where participants expressed strong interests in exploring and integrating AI in the development of herbal medicine.

A Memorandum of Understanding (MOU) was signed between the president of HCOWA, Sihong Jiang and two prominent Ghanaian herbal medicine institutions; Kantanka Herbal Pharmaceutical and Research Centre and The Ghana Association of Medical Herbalists.

This partnership aims to enhance the quality and efficacy of herbal products through collaborative research, development, and commercialization. By combining their expertise, they can improve the healthcare sector in Ghana, marking a significant milestone in promoting traditional medicine in Ghana.

The Health Community of West Africa Association remains at the forefront of innovative healthcare solutions, championing the integration of herbal medicines to enhance medical outcomes and address regional health challenges.

The Director-General of the Ghana Health Service (GHS), Professor Samuel Kaba Akoriyea, has commended the Health Community of West Africa (HCOWA) Association for its groundbreaking efforts in championing the integration of Artificial Intelligence (AI) into Ghana’s healthcare system.

 “Your bold mission and key involvement in launching the HCOWA AI Treatment Project is one that the Ghana Health Service values greatly. AI is transforming the global healthcare landscape, and Ghana must not be left behind,” he stated.

He made these remarks while speaking at the seminar on AI Diagnosis and Treatment Deployment Framework and Application Standards, held in Accra under the theme “Advancing AI Diagnosis and Treatment: Building a Framework for Healthcare Transformation.”

Professor Akoriyea outlined three transformative AI-driven strategies that HCOWA aims to implement within the healthcare sector.

“The first, he explained, is the establishment of AI departments in hospitals, where AI-integrated systems will assist medical professionals in making more accurate diagnoses, reducing human error, and improving efficiency.

“The second is leveraging AI and big data analytics to enhance national disease control, allowing health authorities to track disease patterns, predict outbreaks, and strengthen public health responses.

“The third is the development of an AI-powered medical supply chain system to streamline hospital logistics, ensuring that essential medicines and medical equipment remain in steady supply,” the Director-General said.

“These three pillars of AI integration will work together to enhance Ghana’s healthcare system, improve patient outcomes, and ensure that we stay ahead with faster diagnostic systems, better treatment options, and efficient medical supply management,” he further explained.

However, he also cautioned that while AI presents immense opportunities, its deployment must be handled with care.

“Ghana Health Service is designated as a Critical Information Infrastructure (CII), meaning that disruptions, vulnerabilities, or breaches in our health systems can have severe consequences on national security. While AI offers immense benefits in diagnostics and treatment deployment, it also introduces risks to data privacy, cybersecurity, and ethical use,” he warned.

He assured participants that GHS is taking proactive measures to ensure that AI adoption in healthcare aligns with the Digital Health Strategy (2023-2027) and the Information Security Policy (ISP) 2025, which emphasize strict security, privacy, and ethical considerations.

The seminar saw the participation of healthcare professionals, policymakers, and AI experts from across Ghana and beyond. Delegates from China’s cities of Changsha and Chengdu joined the discussion, along with medical experts from Togo. The event provided a platform for knowledge-sharing on AI’s potential to revolutionize healthcare, with experts demonstrating how AI can enhance diagnostic accuracy and patient care.

A key highlight of the seminar was a presentation by MEDCONN Diagnostics, a company specializing in research and development, manufacturing, and sales of in-vitro diagnostic products. The presentation shed light on the latest innovations in AI-powered diagnostics, showcasing how these technologies can enhance medical imaging and streamline disease detection.

Dr. Marion Okoh-Owusu, Director of the Family Health Division at GHS, also stressed the need for AI in maternal and child healthcare, explaining that AI-powered systems could improve early detection of complications, leading to faster interventions and better survival rates. “Child and maternal health must be at the center of AI adoption in Ghana. We need technologies that enhance early diagnosis, predict complications, and help reduce mortality rates,” she noted.

Adding to the discussion, the President of the Private Health Facilities Association of Ghana, Dr. Kwame Buabeng-Frimpong, emphasized that private hospitals are eager to embrace AI-driven solutions. “There is a growing demand among hospitals for AI departments to support faster diagnoses, improve reporting accuracy, and enhance patient outcomes. AI has the potential to transform our healthcare system, and we must act now rather than later,” he stated.

At the close of the seminar, HCOWA Association reaffirmed its commitment to partnering with the Ghana Health Service to push forward AI adoption in healthcare. The association emphasized that AI-driven innovation is key to transforming healthcare delivery not only in Ghana but across the entire West African sub-region.

“We are dedicated to championing this cause and ensuring that AI becomes an integral part of medical practice in our hospitals. This partnership with GHS will help accelerate the pace of healthcare transformation in Ghana and beyond,” Prince Dogbey, Deputy to the President of HCOWA Association, stated.

As AI continues to reshape the future of medicine worldwide, Ghana is taking proactive steps to integrate this technology responsibly, balancing innovation with security, ethics, and efficiency. The collaboration between GHS and HCOWA marks a significant milestone in the country’s journey toward a smarter, technology-driven healthcare system.

Stakeholders from across West Africa convened at the Tang Palace Hotel in Accra on January 17, 2025, for the 2025 West Africa AI Healthcare Conference and Summit to explore the integration of Artificial Intelligence in healthcare to ease the burden on senior professionals and medical staff.

The 2025 West Africa AI Healthcare Conference and Summit, themed “Promoting the Regional Integration of AI in Healthcare to Enhance Service Delivery,” brought together nearly 150 participants, including healthcare professionals, policymakers, and industry leaders from Ghana, Togo, Sierra Leone, Burkina Faso, Nigeria, Niger, Guinea Conakry, Senegal, Côte d’Ivoire, and Liberia.

The conference, organized by the Health Community of West Africa Association (HCOWAA) addressed the region’s persistent healthcare challenges, including shortages of medical professionals, limited access to diagnostic tools, and the growing burden of both communicable and non-communicable diseases.

Speaking at the conference, Sihong Jiang, President of HCOWAA, emphasized the urgency of leveraging AI to improve healthcare delivery across West Africa.

“AI offers a unique opportunity to bridge gaps in healthcare systems by addressing resource shortages, enhancing efficiency, and delivering personalized care at scale,” she said. Jiang highlighted that AI systems proposed by HCOWAA are 99.9% accurate, making them a reliable tool for tackling pressing healthcare issues.

Jiang also outlined a roadmap for integrating AI into the region’s healthcare systems, including establishing AI treatment departments in hospitals, creating a National Disease Control Center to track and manage outbreaks, and deploying an AI-powered medical supply chain system to prevent stockouts and improve efficiency.

“First, we are planning to initiate AI Treatment Departments in hospitals together with our partners. These departments aim to utilize advanced AI systems to enhance healthcare delivery by supporting the diagnosis of diseases and managing minor illnesses more efficiently, addressing workforce shortages in the process.

“Second, through the AI system, we can control and monitor specific diseases regionally, enabling better management and treatment of similar conditions. By utilizing a National Disease Control System powered by big data, health data from hospitals, clinics, and laboratories can be centralized for real-time tracking.

“Third, the introduction of an AI Medical Supply Chain System will transform how medical supplies, reagents, and equipment are managed. This innovative system will monitor inventory levels in real time, ensuring hospitals avoid stockouts, especially during emergencies,” she explained.

The event featured remarks from key stakeholders, including the President of the Ghana Medical Association (GMA), Dr. Frank Serebour, who described AI as the future of healthcare. He urged regulatory bodies like the Health Facilities Regulatory Agency (HeFRA) to ensure that AI systems introduced in the region are properly licensed and meet professional standards.

He stated that integrating AI into Ghana’s healthcare system could significantly reduce mortality rates, ensure better management of illnesses such as hypertension and diabetes, and enable faster and more accurate diagnoses. He called on the government and stakeholders to collaborate with HCOWAA to make the vision of AI-driven healthcare a reality in Ghana. He commended the initiative, urging HCOWAA to expedite the introduction of its AI medical solutions to improve the country’s healthcare sector.

Nigeria’s High Commissioner to Ghana, Ambassador Dayo Adeoye, praised the initiative, noting that AI could play a vital role in addressing the shortage of healthcare professionals in Ghana and other parts of West Africa. He called for sustained collaboration between countries to maximize the benefits of AI in healthcare.

China’s First Counselor in Charge of Economic Affairs, Li Yaohong, reaffirmed China’s commitment to supporting healthcare advancements in West Africa. “Adopting AI technology is critical for addressing systemic challenges, and the Chinese community stands ready to contribute to this integration,” she said.

The event received significant support from key Chinese organizations, including the Sichuan Provincial Administration of Traditional Chinese Medicine, Health Commission of Sichuan Province, Sichuan Provincial Association for Traditional Chinese Medicine, Sichuan Medical Association, and the China Council for the Promotion of International Trade Sichuan Council.

Additional backing came from the Sichuan Chamber of International Commerce, Chengdu Wenjiang High-Tech Industrial Park, Department of Commerce of Hunan Province, China Council for the Promotion of International Trade Hunan Sub-Council, Hunan University of Medicine, China-Africa Economic and Trade Promotion Council, Yuhua Administration of the Changsha Area of the China (Hunan) Pilot Free Trade Zone, and Hunan University of Chinese Medicine.

Presentations were made on the following topics: AI Diagnostics and Bridging Healthcare Gaps, Digital Imaging in Healthcare, AI-Powered Chinese Traditional Medicine Treatment, AI for Disease Control, Revolutionizing Healthcare with AI-Powered Medical Supply Chains, Harnessing AI to Transform Healthcare Delivery in Ghana and West Africa, and an Overview of HCOWA Association and its Upcoming Event.

The conference concluded with a strong call for actionable steps to turn the vision of integrating AI into healthcare into a reality across West Africa.

In the pursuit of developing a structured framework for the deployment of AI-driven diagnosis and treatment in healthcare, the Health Community of West Africa (HCOWA) Association hosted its second Stakeholder Engagement Seminar on AI Diagnosis and Treatment Deployment.

The seminar, held in Accra, Ghana, on February 21, 2025, brought together key stakeholders, including policymakers, medical professionals, industry leaders, and regulatory bodies, to discuss the integration of AI in medical decision-making.

Under the theme “Advancing AI Diagnosis and Treatment: Building a Framework for Healthcare Transformation,” participants explored strategies for standardizing AI applications, ensuring compliance with healthcare regulations, and strengthening international collaborations to enhance medical services across West Africa. The event served as a crucial platform for shaping policies, addressing challenges, and fostering innovation in AI-driven healthcare solutions.

AI as a Game Changer in Healthcare
Speaking at the seminar, Professor Samuel Kaba Akoriyea emphasized the transformative potential of AI in medical diagnosis and treatment. He highlighted AI’s applications in medical imaging and diagnostics, where technologies such as computer vision and neural networks enhance the analysis of imaging data from X-rays, CT scans, MRIs, PET-CT scans, ultrasounds, and pathology slides. AI-driven solutions have demonstrated the ability to detect conditions such as fractures, lung cancer, liver cancer, skin cancer, and intracranial aneurysms with remarkable accuracy.

“Your bold mission and key involvement in launching the HCOWA AI Treatment Project is one that the Ghana Health Service values greatly. AI is transforming the global healthcare landscape, and Ghana must not be left behind,” Professor Akoriyea stated.

Professor Samuel Kaba Akoriyea underscored the importance of developing a structured framework for AI diagnosis and treatment based on global best practices. He recommended adopting the UNESCO Recommendation on the Ethics of AI, known as the RAM Framework, to guide ethical AI integration in Ghana’s healthcare system.

“The RAM Framework provides a structured approach to AI ethics and governance, emphasizing fairness and inclusion, transparency and accountability, and security and ethical integrity,” he stated.

Professor Akoriyea stressed that AI systems should be designed to benefit all Ghanaians equitably, avoiding biases that could widen health disparities. He emphasized that AI-driven decisions must be explainable and subject to regulatory oversight to ensure fairness and justice. Furthermore, he highlighted the need for stringent security measures to protect patient confidentiality and prevent unethical data usage.

“These principles are key to advancing AI diagnosis and treatment in healthcare, ensuring that technology serves as an enabler of improved medical outcomes while upholding ethical standards,” he concluded.

He further stressed the importance of a structured AI adoption framework that ensures responsible AI use in medical decision-making. He noted that AI should complement rather than replace human clinical judgment, with healthcare professionals validating AI-driven diagnoses before implementation.

“We must ensure that AI serves as a tool to enhance, not undermine, the expertise of our medical professionals,” he added.

He also underscored the need for robust data protection measures to prevent AI misuse and bias, emphasizing compliance with Ghana’s data protection regulations to safeguard patient information.

HCOWA’s Role in AI-Driven Healthcare Transformation

Delivering a keynote address, Ms. Liu Suhua, Chief Secretary – China for the HCOWA Association, reiterated HCOWA’s commitment to fostering AI-driven healthcare transformation in West Africa. She highlighted the association’s role in bridging technological gaps, ensuring AI integration aligns with healthcare standards, and enhancing patient outcomes.

“The HCOWA Association is poised for transformative change in the healthcare industry. By establishing clear deployment frameworks and ensuring cross-border collaboration, we are setting the stage for AI-driven medical advancements,” she stated.

Economic and Social Benefits of AI Adoption

Touching on the economic potential of AI, Mr. Anthony Ameka, CEO of the Federation of Africa Medical Equipment Disposables and Devices Manufacturers and Suppliers, noted that AI is projected to add $15.7 trillion to the global economy by 2030.

He outlined how AI can stimulate economic growth, drive innovation, create new industries, and enhance job opportunities across Africa.

“AI can help solve some of Africa’s most urgent healthcare challenges, while also preserving cultural heritage and generating new business opportunities,” he noted.

Compliance and Ethical Considerations

Experts at the seminar underscored the importance of complying with regulatory standards set by the Health Facilities Regulatory Agency (HeFRA) and the Food and Drugs Authority (FDA). They emphasized that patient safety and ethical AI use should remain a priority to build public trust and ensure smooth integration into existing healthcare structures.

Strengthening International Collaboration

A key milestone of the seminar was the emphasis on international partnerships to enhance AI-driven healthcare solutions. Collaborations with leading institutions in China and across West Africa will foster knowledge exchange, technological advancement, and improved medical services in the region.

The Health Community of West Africa (HCOWA) Association has appointed key professionals to leadership roles to drive healthcare integration in the region. Dr. Paulina Denteh will lead as Director of Women’s Health & Wellness, focusing on maternal care and gender-specific health issues. Dr. George Henry Acquah, appointed as Director of Public Health and Policy, will spearhead evidence-based policies to enhance public health systems. Dr. Selina Leward, as Director of HPV Awareness and Preventive Care, will lead advocacy efforts on HPV vaccinations and screenings. These appointments reinforce HCOWA’s commitment to strengthening healthcare frameworks and improving medical outcomes in West Africa.

Strategic Plan for AI Implementation

The seminar concluded with a strategic roadmap for AI adoption in healthcare. The action plan includes compiling key seminar outcomes into an official document for stakeholder reference, followed by an extensive review and feedback process. Additionally, policymakers, medical institutions, and technology developers will be engaged to assess the findings and ensure a well-rounded approach to AI implementation.

Aligning the AI framework with regulatory guidelines from the Health Facilities Regulatory Agency (HeFRA) and the Food and Drugs Authority (FDA) is a crucial step in streamlining approvals. Moreover, actionable implementation plans will be developed, including training programs and structured deployment schedules, to equip healthcare institutions with the necessary tools for effective AI adoption.

To broaden its impact, the seminar allowed participation from healthcare professionals, policymakers, and AI experts across different regions. The event saw active engagement from Changsha (15 participants) and Chengdu (12 participants) in China, along with 15 attendees from Togo.

Conclusion

The second HCOWA Stakeholder Seminar on AI Diagnosis and Treatment Framework reinforced the urgent need for structured AI adoption in West Africa’s healthcare landscape. With growing collaboration between governments, private stakeholders, and international partners, AI is set to play a crucial role in transforming healthcare delivery across the region.

HCOWA remains committed to driving innovation and ensuring that AI technologies are deployed responsibly, ethically, and efficiently to improve health outcomes for all. The seminar marks a significant step forward in building a sustainable AI-powered healthcare ecosystem in West Africa.

The Health Community of West Africa (HCOWA) Association has successfully held its Third Conference today, 7th March 2025, under the theme:Harnessing AI and IVD: Leading a New Era of Precision Diagnosis and Advanced Treatment.

This significant event, which is part of a broader conference series launched by HCOWA in January 2025, focuses on Integrating Artificial Intelligence (AI) into the health sector across West Africa. The conference brought together key stakeholders, including representatives from Ghana Health Service, the Ghana College of Physicians and Surgeons, the Nigeria Society of Physiotherapy, and leading Chinese AI experts.

Keynote Address Emphasizes AI’s Transformative Potential

The conference opened with an insightful keynote address delivered by Professor Samuel Debrah, who highlighted the growing involvement of global technology giants such as Apple, Microsoft, and Amazon in AI-driven healthcare innovation. Professor Debrah underscored how these companies are leveraging AI to improve disease diagnosis, treatment development, and preventive care.

While acknowledging the transformative potential of AI, Professor Debrah also highlighted critical ethical and regulatory issues surrounding its adoption. He stressed the need for robust data privacy protections, safeguards against algorithmic bias, and compliance with regulatory and professional standards to ensure that AI serves as a tool for empowerment rather than exclusion.

HCOWA President Calls for Regional Collaboration

In his opening remarks, the President of the Health Community of West Africa Association emphasized the strategic importance of this conference for West Africa’s healthcare future. He noted that with health systems across the region facing mounting challenges, the adoption of AI and advanced diagnostic technologies could play a vital role in improving early detection, treatment accuracy, and patient outcomes, especially in underserved communities.

The President further stressed that collaboration between governments, private sector innovators, and health institutions is essential to ensuring that technological advancements benefit the entire population, leaving no one behind.

Panel Discussion Explores AI and IVD Integration

A panel discussion featuring five distinguished experts formed a core segment of the conference. Panelists provided in-depth perspectives on the integration of AI and in vitro diagnostic (IVD) technologies into healthcare systems across West Africa.

The panel explored how AI-powered diagnostics can enhance clinical decision-making, enable personalized treatment plans, and support telemedicine initiatives, particularly in rural and remote areas.

While the experts highlighted the numerous benefits of AI in enhancing diagnostic accuracy and improving operational efficiencies, they also cautioned against potential risks, including data misuse, technological inequality, and the need for regulatory oversight.

 They stressed the importance of upskilling healthcare professionals, building digital infrastructure, and establishing strong ethical frameworks to guide the responsible deployment of AI technologies in healthcare.

Virtual Symposium Enhances Regional Participation

The conference attracted approximately 100 online participants, including representatives from hospitals, medical institutions, and healthcare professionals from across West Africa.

This virtual engagement allowed for real-time contributions, enabling participants to ask questions, share experiences, and provide regional insights during the discussions. The interactive platform fostered knowledge exchange and cross-border collaboration, helping to shape a common understanding of the opportunities and challenges surrounding AI adoption in West African healthcare systems.

Shaping the Future of AI and Smart Diagnostics

As the conference concluded, several key recommendations emerged to guide the integration of artificial intelligence and smart diagnostics into healthcare systems across West Africa. One of the primary recommendations highlighted the urgent need for greater investment in digital health infrastructure to support the seamless adoption of AI technologies.

 Participants also stressed the importance of developing comprehensive capacity-building programs aimed at equipping healthcare professionals with the necessary skills and knowledge to effectively utilize AI tools in clinical settings. Additionally, the conference underscored the need for clear regulatory and ethical guidelines to govern the deployment of AI in healthcare, ensuring patient safety, data privacy, and equitable access to advanced diagnostic solutions.

 Another vital recommendation focused on strengthening regional cooperation to facilitate the sharing of data, the exchange of best practices, and the collaborative development of innovative healthcare solutions tailored to the specific needs of West African countries.

The Health Community of West Africa Association reaffirmed its commitment to promoting innovation, driving technology adoption, and enhancing capacity building across the region’s health systems, ensuring that the transformative potential of AI and smart diagnostics contributes to the advancement of healthcare for all.

The success of this third conference sets the stage for continued dialogue, collaboration, and action aimed at ensuring that AI and smart diagnostics play a transformative role in strengthening healthcare delivery across West Africa.

In a keynote address delivered by Her Diviness Naa Juyoo Oshedu Wobolor Jueteer Tsofayelor, at the recently concluded 3rd AI Conference in Healthcare organized by the Health Community of West Africa Association, the traditional health advocate has emphasized the vital role of cultural awareness in improving healthcare accessibility.

Speaking passionately under the theme “The Social Impact of AI-Driven Diagnostics and How Culture Influences Healthcare Accessibility,” she outlined how integrating traditional and modern healthcare systems can transform patient outcomes, especially in sensitive areas like mental health, sexual health, and other culturally specific conditions.

Opening with a warm greeting, she set the stage for a discussion on the intersection of AI-driven diagnostics and the cultural frameworks that shape healthcare acceptance. According to her, teamwork, collaboration, adaptation, and implementation are crucial for the success of healthcare initiatives. However, she cautioned that a lack of cultural understanding by healthcare providers often leads to the rejection of their services.

She stressed the importance of involving community and traditional leaders in the introduction and implementation of healthcare programs. “Every land has an owner, and every group has a leader,” she asserted, urging healthcare professionals to respect traditional protocols and seek permission before entering communities. She believes this approach is essential for earning trust and ensuring successful healthcare delivery.

By consulting traditional structures, healthcare providers can better identify and support marginalized groups, including individuals with mental illnesses, intersex persons, and those living with HIV. She highlighted the need for gender-sensitive healthcare services, noting cultural beliefs that may prevent opposite-sex healthcare providers from conducting intimate medical examinations. In these situations, patients often withhold critical health information, leading to misdiagnoses and ineffective treatments.

The keynote address emphasized how AI can enhance healthcare accessibility through research, cultural competency, and health education. AI-driven tools can provide culturally sensitive recommendations and modernize indigenous healing practices rather than dismiss them outright. She compared Ghana’s hesitancy to standardize local herbal remedies like Odidoo with China’s global acceptance of traditional tea-based medicine, advocating for a balance between tradition and innovation.

Concluding with a proud declaration of her cultural heritage, she reaffirmed her commitment to preserving and integrating traditional knowledge into modern healthcare. “When tradition meets modernity, it is always progressive,” she proclaimed, urging stakeholders to embrace collaboration for a more inclusive and effective healthcare system.

This address laid the groundwork for the panel discussions held under the theme “Harnessing AI and IVD: Leading a New Era of Precision Diagnosis and Advanced Treatment,” as part of the 3rd edition of HCOWA’s conferences exploring Artificial Intelligence in healthcare.

Neonatal Abstinence Syndrome refers to a condition that occurs when a newborn baby is exposed to opioids or other substances such as benzodiazepines or barbiturates during pregnancy, which leads to withdrawal symptoms after childbirth ranging from mild to severe, including tremors, irritability, fever, and seizures.

How Does This Happen?

1. Pregnant women who use opioids, whether prescribed or illicit, are likely to pass the substances to their baby.

2. Pregnant women who undergo treatment for opioid use disorder through receiving medication-assisted treatment can still pass opioids to their babies.

3. Also, babies can be exposed to opioids or other substances through living in an environment or household where these substances are being used.

Symptoms.

Babies typically experience common symptoms of NAS within the first week after they are born but can occur up to 2 weeks afterwards. These common symptoms often include tremors, fever, seizures, vomiting, diarrhea, excessive sweating, frequent yawning, and congestion.

Diagnosis.

For diagnosis, a thorough review of the mother’s medical history, especially substance usage, a physical examination of the newborn to assess for symptoms, and urine or blood tests are conducted to detect the presence of opioids or other substances.

Treatment.

If it is confirmed that a baby has NAS, medications such as morphine or methadone are used to help manage the withdrawal symptoms. The baby undergoes supportive care like hydration, nutrition, and comfort measures, whereas there are non-pharmacological interventions such as swaddling or rocking the baby to help soothe it.

Prevention.

Prevention involves regular prenatal care for the mother’s health to be monitored in order to detect any potential issues, and then treatment for substance usage can begin. Additionally, potential mothers need to be counseled and educated on the risks and preventive methods.

A recent study published in Frontiers in Pediatrics (March 2025) found that infants with NAS have a higher risk of infant mortality and hospitalizations during their first year after being born. However, the study also noted that the association between NAS and infant mortality diminished after adjusting for other factors such as maternal health and socioeconomic status.

Despite that, researchers have been working to better understand and develop effective treatments for NAS. Another important finding from the study shows that infants with NAS are more likely to experience post-discharge hospitalizations and stay longer at the hospital; hence, the need for ongoing support and care for these infants even after they have been discharged from the hospital.

Overall, the advances in NAS research are essential in addressing this critical health issue. Through the continuation to study and understand NAS, researchers can provide more effective ways for healthcare professionals to treat and improve the lives of affected infants and their families.

Babies should be our priority since they are our future leaders.

Source : Lee, J., et al. (2025). Neonatal Abstinence Syndrome: A Systematic Review and Meta-Analysis. Frontiers in Pediatrics, 13.

Acute migraine is known as a neurological disorder characterized by recurrent episodes of severe headaches usually accompanied by sensitivity to light, sound, and nausea. Migraines can negatively impact an individual’s quality of life, such as emotional distress, social isolation, and even missed workdays.

There are medications such as triptan, ergotamine, and other over-the-counter pain medicines to help with the pain; however, these treatments may not be effective for everyone, as everyone experiences different effects. Hence, the new guidelines from the American College of Physicians (ACP) for the treatment of acute migraine aim to improve the management and treatment, reducing the burden of this condition.

There are updated recommendations such as

1. Thorough assessment and diagnosis of an individual, including a detailed medical history as well as a physical examination of the affected person. Healthcare practitioners are encouraged to use triptan, ergotamine, and anti-nausea medications as the first line of treatment and then develop personalized treatment plans.

2. Healthcare professionals are encouraged to advise their patients on their lifestyle modifications, like maintaining a consistent sleep schedule, which is getting 7-8 hours of sleep, avoiding triggers that can cause migraines, such as certain foods or stress, and practicing stress-reducing methods like meditating or deep breathing.

3. Patients should be educated on their treatment options and how to manage their symptoms based on their specific needs and medical history, and then follow-up care should be provided in order for healthcare professionals to monitor the individual’s response to treatment and make the necessary adjustments needed.

4. There are also recommendations on an individual’s lifestyle to help avoid acute migraines, such as identifying and avoiding foods that can trigger migraines, usually gluten, dairy, citrus fruits, or foods containing tyramine or MSG; ensuring to eat your meals regularly to prevent low blood sugar; and consuming foods that are rich in magnesium and vitamin B2, such as dark leafy greens and whole grains, or considering supplements after consulting with a healthcare provider.

The old guidelines for treating acute migraine recommended various medications, including acetaminophen, NSAIDs, triptans, and antiemetics, along with personalized treatment plans and lifestyle modifications.

However, the new guidelines provide a more comprehensive approach to dealing with acute migraines with their updated recommendations for treatment. Some benefits are improved treatment outcomes, patient satisfaction, and reduced healthcare costs through minimizing the need for frequent hospital visits.

Source: American College of Physicians.

The World Health Organization (WHO) has emphasized the need for an integrated approach to combat tuberculosis (TB) and lung health, focusing on people-centered care and the social factors of healthcare.

This approach recognized that TB is often linked to other health conditions like HIV, diabetes, and malnutrition; hence, the approach seeks to address these underlying conditions as well. The WHO noted that TB remains the world’s deadliest infectious disease, responsible for over 1 million deaths annually. Despite progress made in combating TB, global efforts are being threatened by drastic cuts in terms of funding, rising drug resistance, and ongoing conflicts.

Tuberculosis is known as a bacterial infection caused by a mycobacterium tuberculosis that affects the lungs as well as other parts of the body. Symptoms may include coughing, chest pain, coughing up blood, fatigue, weight loss, reoccurring fever, sweating at night, and chills.

Some determinants are malnutrition, smoking, people with a weak immune system like those with HIV/AIDS, adults and young children, and having close contact with an infected person.

For diagnosis, a chest X-ray, sputum test, blood test, or tuberculin skin test can be done to detect the presence of the bacteria that cause TB in the body. The new guidelines released by WHO are organized into five modules:

Module 1: Prevention. This focuses on adhering to the preventive measures such as practicing good hygiene, regular screenings, and vaccinations, as well as avoiding close contact with an infected person.

Module 2: Screening. This includes 17 new updated recommendations for screening and prioritizing populations like affected patients, people living with HIV, and those in prisons.

Module 3: Diagnosis. For rapid TB detection, three new classes of nucleic acid amplification tests (NAATs) have been endorsed.

Module 4: Treatment. This provides updates on drug-resistant TB treatment, a 6-month BPaLM regimen, and a 9-month all-oral regimen.

Module 5: Comorbidities, Vulnerable Populations, and People-Centered Care addresses the management of TB in children, adolescents, and susceptible individuals.

According to WHO, the cure rate for the new cases of TB is around 85%; however, this can vary depending on factors such as the severity of the disease, the presence of drug-resistant TB, and a patient’s adherence to treatment prescribed by medical experts.

To conclude, TB can be cured with proper treatment and a patient’s adherence to treatment to prevent relapse. As an individual, always complete your full treatment course, which is usually taken about six to nine months, ensure to attend follow-up appointments, and practice good hygiene.

Source: World Health Organization.

In a bid to provide top-notch medical services to the Ghanaian community, MAB International Hospital, located at Nyamekye—Accra, has emerged as a beacon of hope. With over 10 years of experience in private healthcare as a clinic, hospital, and training center, MAB International Hospital is redefining healthcare in Ghana by focusing on accessibility, affordability, and compassionate patient care.

The Health Pulse Magazine covered an exclusive with the Executive Director of the hospital, Mr. Opare Akuamoah-Boateng, who tells the story of the facility with a strong emphasis on maternal and child health.

MAB International Hospital boasts an impressive array of cutting-edge facilities, including a soon-to-be-launched dialysis center, slated for completion by the end of May. The hospital’s X-ray department is equipped with the latest technology, and plans are underway to acquire ultra-modern MRI and CT scan machines. The laboratory is fitted with the latest machines, ensuring accurate and efficient diagnostic services.

During the interview, he highlighted their commitment to patient satisfaction, emphasizing the hospital’s unique approach, which ensures that patients receive prompt attention, with a protocol in place to guarantee a doctor’s consultation within 10 minutes of check-in. A team of dedicated nurses is always available to provide assistance, making the healthcare experience as seamless as possible.

“Our wards are designed to be home-friendly, creating a warm and welcoming atmosphere that helps boost patients’ moods during recovery. The hospital’s priority is clear: to make patients feel at home, even when they’re away from their loved ones.” Said Mr. Opare Akuamoah-Boateng.

Additionally, the hospital offers affordable services, accepting payments from the National Health Insurance Scheme (NHIS). They are also committed to giving back to the community, having visited a local orphanage to provide free screening services and medications. This course of action is conducted at least once every month, demonstrating its dedication to social responsibility.

Despite facing challenges with reimbursement from partners and funding, the hospital’s future plans include becoming an ultra-modern facility equipped to treat cancer, a significant step forward for healthcare in Ghana.

As the country continues to navigate the healthcare landscape, MAB Hospital stands as a shining example of innovation and compassion. With its patient-centric approach, advanced medical equipment, and a commitment to community outreach, this hospital is revolutionizing healthcare in Ghana, one patient at a time.